Compare WLYB & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLYB | TWST |
|---|---|---|
| Founded | 1807 | 2013 |
| Country | United States | United States |
| Employees | 5200 | N/A |
| Industry | Books | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 3.0B |
| IPO Year | N/A | 2018 |
| Metric | WLYB | TWST |
|---|---|---|
| Price | $36.71 | $44.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $48.75 |
| AVG Volume (30 Days) | 230.0 | ★ 928.8K |
| Earning Date | 03-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.89% | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $0.02 | $18.91 |
| Revenue Next Year | $2.32 | $15.07 |
| P/E Ratio | $15.27 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $29.16 | $23.30 |
| 52 Week High | $45.16 | $57.88 |
| Indicator | WLYB | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 65.39 | 47.30 |
| Support Level | $36.20 | $41.69 |
| Resistance Level | $38.63 | $45.76 |
| Average True Range (ATR) | 0.33 | 2.63 |
| MACD | 0.60 | -0.49 |
| Stochastic Oscillator | 94.35 | 35.17 |
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.